Plasma adiponectin is modestly decreased during 24‐hour insulin infusion but not after inhibition of lipolysis by Acipimox

References

• Fasshauer M., Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003; 46: 1594–603
   PubMed Web of Science ®Google Scholar
• Goldfine A. B., Kahn C. R. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003; 362: 1431–2
   PubMed Web of Science ®Google Scholar
• Matsusawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29–33
   PubMed Web of Science ®Google Scholar
• Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet‐induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731–7
   PubMed Web of Science ®Google Scholar
• Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat‐derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941–6
   PubMed Web of Science ®Google Scholar
• Yamamoto Y., Hirose H., Saito I., Nishikai K., Saruta T. Adiponectin, an adipocyte‐derived protein, predicts future insulin resistance: two year follow‐up study in a Japanese population. J Clin Endocrinol Metab 2004; 89: 87–90
   PubMed Web of Science ®Google Scholar
• Pischon T., Girman C. J., Hotamisligil G. S., Rifai N., Hu F. B., Rimm E. B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–7
   PubMed Web of Science ®Google Scholar
• Scherer P. E., Williams S., Fogliano M., Baldini G., Lodish H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746–9
   PubMed Web of Science ®Google Scholar
• Ferré P. The biology of peroxisome proliferator‐activated receptors. Relationship with lipid metabolism and insulin sensitivity. Diabetes 2004; 53(Suppl 1)S43–S50
   PubMed Web of Science ®Google Scholar
• Yu J. G., Javorschi S., Hevener A. L., Kruszynska Y. T., Norman R. A., Sinha M., et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002; 51: 2968–74
   PubMed Web of Science ®Google Scholar
• Halleux C. M., Takahashi M., Delporte M. L., Detry R., Funahashi T., Matsusawa Y., et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Comm 2001; 288: 1102–7
   PubMed Web of Science ®Google Scholar
• Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3‐L1 adipocytes. Biochem Biophys Res Comm 2002; 290: 1084–9
   PubMed Web of Science ®Google Scholar
• Viengchareun S., Zennaro M‐C., Pascual‐Le Tallec L., Lombes M. Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin. FEBS Lett 2002; 532: 345–50
   PubMed Web of Science ®Google Scholar
• Bogan J. S., Lodish H. F. Two compartments for insulin‐stimulated exocytosis in 3T3‐L1 adipocytes defined by endongenous ACRP30 and Glut4. J Cell Biol 1999; 146: 609–20
   PubMed Web of Science ®Google Scholar
• Blüher M., Michael M. D., Peroni O. D., Ueki K., Carter N., Kahn B. B., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity‐related glucose intolerance. Dev Cell 2002; 3: 25–38
   PubMed Web of Science ®Google Scholar
• Möhlig M., Wegewitz U., Osterhoff M., Isken F., Ristow M., Pfeiffer A. F. H., et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res 2002; 34: 655–8
   PubMed Web of Science ®Google Scholar
• Christie A. W., McCornick D. K., Emmison N., Kraemer F. B., Alberti K. G. M. M., Yeaman S. J. Mechanism of anti‐lipolytic action of acipimox in isolated rat adipocytes. Diabetologia 1996; 39: 45–53
   PubMed Web of Science ®Google Scholar
• Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a World Health Organization consultation. Part 1: diagnosis and classification of diabetes mellitus (WHO/NCD/NCS/99.2). 1999
   Google Scholar
• Kern P. A., Di Gregorio G. B., Lu T., Rassouli N., Ranganathan G. Adiponectin expression from human adipose tissue. Relation to obesity, insulin resistance, and tumor necrosis factor‐α expression. Diabetes 2003; 52: 1779–85
   PubMed Web of Science ®Google Scholar
• Ostlund R. E., Saten M., Kohrt W. M., Schultz J., Malley M. The ratio of waist‐to‐hip circumference, plasma insulin level and glucose tolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 1990; 322: 229–34
   PubMed Web of Science ®Google Scholar
• Jensen M. D., Heiling V. J. Heated hand vein blood is satisfactory for measurements during free fatty acid kinetic studies. Metabolism 1991; 40: 406–9
   PubMed Web of Science ®Google Scholar
• Veneman T., Mitrakou A., Mokan M., Cryer P., Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfynction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes 1994; 43: 1311–7
   PubMed Web of Science ®Google Scholar
• Hoffstedt J., Arvidsson E., Sjölin E., Wåhlén K., Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 1391–6
   PubMed Web of Science ®Google Scholar
• Staiger H., Tschritter O., Kausch C., Lammers R., Stumvoll M., Häring H‐U. Human serum adiponectin levels are not under short‐term negative control by free fatty acids in vivo. Horm Metab Res 2002; 34: 601–3
   PubMed Web of Science ®Google Scholar
• Weyer C., Funahashi T., Tanaka S., Hotta K., Matsusawa Y., Pratley R. E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–5
   PubMed Web of Science ®Google Scholar
• Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose‐specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–9
   PubMed Web of Science ®Google Scholar
• Putz D. M., Goldner W. S., Bar R. S., Haynes W. G., Sivitz W. I. Adiponectin and C‐reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism 2004; 53: 1454–61
   PubMed Web of Science ®Google Scholar
• Rizza R. A., Mandarino L. J., Genest J., Baker B. A., Gerich J. E. Production of insulin resistance by hyperinsulinemia in man. Diabetologia 1985; 28: 70–5
   PubMed Web of Science ®Google Scholar